Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD: Ethnic differenecs in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care 31:798–801, 2008
The LDL and HDL cholesterol values in Table 1 of the article above should be switched to appear as corrected in the table below. The online version reflects these changes.
Table 1—
Comparison of demographic and metabolic variables in South Asian (SA) and Caucasian (CAU) women and insulin-resistant (IR) and insulin-sensitive (IS) subgroups of these ethnicities
| . | SAs . | CAUs . | P . | SAs . | . | . | CAUs . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | IR . | IS . | P . | IR . | IS . | P . | ||||
| n | 30 | 22 | 14 | 16 | 8 | 14 | |||||||
| Age (years) | 45 ± 9 | 47 ± 8 | 0.3 | 44 ± 8 | 45 ± 11 | 0.7 | 47 ± 5 | 47 ± 9 | 1 | ||||
| BMI (kg/m2) | 28.6 ± 2.6 | 28.5 ± 4.4 | 1.0 | 28.9 ± 2.1 | 28.3 ± 3 | 0.5 | 31.6 ± 4.7 | 26.8 ± 3.2 | 0.01 | ||||
| Cigarette use (%) | 0 (0) | 8 (36) | <0.001 | 0 (0) | 0 (0) | — | 2 (25) | 6 (43) | 0.4 | ||||
| SBP (mmHg) | 117 ± 19 | 119.2 ± 14.7 | 0.603 | 114 ± 20 | 119 ± 19 | 0.4 | 123 ± 16 | 117 ± 15 | 0.4 | ||||
| DBP (mmHg) | 70 ± 10 | 71 ± 9 | 0.7 | 68.9 ± 10 | 70.7 ± 10.6 | 0.7 | 73 ± 9 | 70 ± 9 | 0.4 | ||||
| SSPG (mg/dl) | 157 ± 7 | 138 ± 56 | 0.3 | 225 ± 54 | 98 ± 21 | <0.0001 | 204 ± 24 | 100 ± 21 | <0.001 | ||||
| FPG (mg/dl) | 93 ± 10 | 93 ± 9 | 0.9 | 95 ± 11 | 91 ± 9 | 0.3 | 97 ± 9 | 91 ± 9 | 0.2 | ||||
| Total cholesterol (mg/dl) | 176 ± 3 | 198 ± 39 | 0.027 | 181 ± 38 | 172 ± 24 | 0.5 | 188 ± 30 | 204 ± 44 | 0.4 | ||||
| LDL cholesterol (mg/dl) | 108 ± 22 | 120 ± 32 | 0.094 | 43 ± 9 | 54 ± 11 | 0.009 | 50 ± 10 | 56 ± 11 | 0.2 | ||||
| HDL cholesterol (mg/dl) | 49 ± 11 | 54 ± 11 | 0.099 | 108 ± 29 | 107 ± 15 | 0.9 | 110 ± 24 | 126 ± 35 | 0.3 | ||||
| Triglycerides (mg/dl) | 123 ± 72 | 123 ± 70 | 0.992 | 158 ± 82 | 93 ± 46 | 0.01 | 142 ± 64 | 113 ± 74 | 0.4 | ||||
| Adiponectin (ng/ml) | 2,965 ± 1,278 | 4235 ± 160 | 0.003 | 2,589 ± 821 | 3,293 ± 1525 | 0.1 | 2,665 ± 1,040 | 5,133 ± 1,086 | <0.001 | ||||
| HMW adiponectin (ng/ml) | 1,001 ± 352 | 1,591 ± 854 | 0.001 | 908 ± 256 | 1,083 ± 410 | 0.2 | 987 ± 479 | 1,935 ± 838 | 0.009 | ||||
| . | SAs . | CAUs . | P . | SAs . | . | . | CAUs . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | IR . | IS . | P . | IR . | IS . | P . | ||||
| n | 30 | 22 | 14 | 16 | 8 | 14 | |||||||
| Age (years) | 45 ± 9 | 47 ± 8 | 0.3 | 44 ± 8 | 45 ± 11 | 0.7 | 47 ± 5 | 47 ± 9 | 1 | ||||
| BMI (kg/m2) | 28.6 ± 2.6 | 28.5 ± 4.4 | 1.0 | 28.9 ± 2.1 | 28.3 ± 3 | 0.5 | 31.6 ± 4.7 | 26.8 ± 3.2 | 0.01 | ||||
| Cigarette use (%) | 0 (0) | 8 (36) | <0.001 | 0 (0) | 0 (0) | — | 2 (25) | 6 (43) | 0.4 | ||||
| SBP (mmHg) | 117 ± 19 | 119.2 ± 14.7 | 0.603 | 114 ± 20 | 119 ± 19 | 0.4 | 123 ± 16 | 117 ± 15 | 0.4 | ||||
| DBP (mmHg) | 70 ± 10 | 71 ± 9 | 0.7 | 68.9 ± 10 | 70.7 ± 10.6 | 0.7 | 73 ± 9 | 70 ± 9 | 0.4 | ||||
| SSPG (mg/dl) | 157 ± 7 | 138 ± 56 | 0.3 | 225 ± 54 | 98 ± 21 | <0.0001 | 204 ± 24 | 100 ± 21 | <0.001 | ||||
| FPG (mg/dl) | 93 ± 10 | 93 ± 9 | 0.9 | 95 ± 11 | 91 ± 9 | 0.3 | 97 ± 9 | 91 ± 9 | 0.2 | ||||
| Total cholesterol (mg/dl) | 176 ± 3 | 198 ± 39 | 0.027 | 181 ± 38 | 172 ± 24 | 0.5 | 188 ± 30 | 204 ± 44 | 0.4 | ||||
| LDL cholesterol (mg/dl) | 108 ± 22 | 120 ± 32 | 0.094 | 43 ± 9 | 54 ± 11 | 0.009 | 50 ± 10 | 56 ± 11 | 0.2 | ||||
| HDL cholesterol (mg/dl) | 49 ± 11 | 54 ± 11 | 0.099 | 108 ± 29 | 107 ± 15 | 0.9 | 110 ± 24 | 126 ± 35 | 0.3 | ||||
| Triglycerides (mg/dl) | 123 ± 72 | 123 ± 70 | 0.992 | 158 ± 82 | 93 ± 46 | 0.01 | 142 ± 64 | 113 ± 74 | 0.4 | ||||
| Adiponectin (ng/ml) | 2,965 ± 1,278 | 4235 ± 160 | 0.003 | 2,589 ± 821 | 3,293 ± 1525 | 0.1 | 2,665 ± 1,040 | 5,133 ± 1,086 | <0.001 | ||||
| HMW adiponectin (ng/ml) | 1,001 ± 352 | 1,591 ± 854 | 0.001 | 908 ± 256 | 1,083 ± 410 | 0.2 | 987 ± 479 | 1,935 ± 838 | 0.009 | ||||
Data are means ± SD. DBP, diastolic blood pressure; FPG, fasting plasma glucose; SBP, systolic blood pressure. Data in bold indicate statistical significance.
DIABETES CARE
2008
